Clinical Trials Directory

Trials / Completed

CompletedNCT05430503

Long COVID and Post-exertional Pulmonary Diffusion

Lung Diffusing Capacities for Nitric Oxide and Carbon Monoxide in Long COVID With Dyspnea at Rest and After Mild Exercise

Status
Completed
Phase
Study type
Observational
Enrollment
32 (actual)
Sponsor
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Aim of investigators was to study whether abnormalities of lung diffusing capacity for nitric oxide (DLNO) and carbon monoxide (DLCO) in long COVID may have a clinical impact in relation to exercise intolerance.

Detailed description

Prolonged recovery from acute coronavirus disease 2019 (long COVID) is characterized in about 30% of subjects from breathlessness and fatigue also during daily activities often associated to decreased lung diffusing capacity for carbon monoxide (DLCO) at rest. Aim of investigators was to study whether abnormalities of lung diffusing capacity for nitric oxide (DLNO) and DLCO in long COVID may have a clinical impact in relation to exercise intolerance. Combined DLNO and DLCO were simultaneously measured at rest and immediately after a short bout of treadmill walking in 32 dyspneic subjects ≥3 months after the COVID-19 acute phase. A group of healthy subjects served as a control group.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLung volumes, spirometry and standard single-breath DLCO were measured at rest while combined DLNO and DLCO were measured at rest and post-exerciseDLNO and DLCO were measured at rest and 5-10 s after a bout of treadmill exercise simulating usual walking

Timeline

Start date
2022-05-24
Primary completion
2022-06-15
Completion
2022-06-15
First posted
2022-06-24
Last updated
2022-06-24

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05430503. Inclusion in this directory is not an endorsement.